{"analyses":[{"ciLowerLimit":"0.19","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.79","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.3418","paramType":"Hazard Ratio (HR)","paramValue":"0.58","statisticalMethod":"Log Rank"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.71","upperLimit":"0.96","value":"0.96"},{"groupId":"OG001","lowerLimit":"1.00","upperLimit":"1.00","value":"1.00"}]}],"title":"6 months"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.56","upperLimit":"0.89","value":"0.89"},{"groupId":"OG001","lowerLimit":"0.69","upperLimit":"0.96","value":"0.89"}]}],"title":"12 months"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.54","upperLimit":"0.89","value":"0.76"},{"groupId":"OG001","lowerLimit":"0.65","upperLimit":"0.94","value":"0.85"}]}],"title":"18 months"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.54","upperLimit":"0.89","value":"0.76"},{"groupId":"OG001","lowerLimit":"0.65","upperLimit":"0.94","value":"0.85"}]}],"title":"24 months"}],"denoms":[{"counts":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"30"}],"units":"Participants"}],"description":"Overall survival was defined as the time from transplant to death due to any cause.","dispersionType":"95% Confidence Interval","groups":[{"description":"Patients received standard of care in the post stem cell transplant (SCT) setting in addition to Midostaurin 50mg twice a day for 12 months (cycles).","id":"OG000","title":"Standard of Care With Midostaurin"},{"description":"Patients received standard of care alone in the post SCT setting","id":"OG001","title":"Standard of Care"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"date of transplant up to 24 months","title":"Probability of Overall Survival - Date of Transplant up to 24 Months (Full Analysis Set) by Kaplan-Meier Analysis","type":"SECONDARY","unitOfMeasure":"proportion of participants"}